Sarah Simon Jackson, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Biliary Tract Neoplasms | 5 | 2021 | 177 | 2.550 |
Why?
|
Gallbladder Neoplasms | 5 | 2022 | 182 | 1.930 |
Why?
|
Cross Infection | 9 | 2019 | 1414 | 1.350 |
Why?
|
Transsexualism | 2 | 2023 | 173 | 1.350 |
Why?
|
Gallstones | 3 | 2024 | 286 | 1.100 |
Why?
|
Gram-Positive Bacterial Infections | 2 | 2018 | 341 | 1.070 |
Why?
|
Common Bile Duct Neoplasms | 3 | 2022 | 110 | 1.040 |
Why?
|
Risk Adjustment | 4 | 2018 | 591 | 1.030 |
Why?
|
Neoplasms | 8 | 2024 | 21507 | 0.950 |
Why?
|
Ampulla of Vater | 3 | 2022 | 141 | 0.890 |
Why?
|
Neoplasms, Complex and Mixed | 1 | 2022 | 31 | 0.820 |
Why?
|
Sesamoid Bones | 1 | 2021 | 13 | 0.820 |
Why?
|
Protective Clothing | 2 | 2019 | 102 | 0.800 |
Why?
|
Hallux | 1 | 2021 | 39 | 0.790 |
Why?
|
Chemokine CCL20 | 1 | 2021 | 63 | 0.770 |
Why?
|
Skiing | 1 | 2020 | 24 | 0.750 |
Why?
|
Gloves, Protective | 3 | 2018 | 22 | 0.750 |
Why?
|
Dancing | 1 | 2021 | 101 | 0.730 |
Why?
|
Sprains and Strains | 1 | 2020 | 78 | 0.720 |
Why?
|
Chemokine CXCL10 | 1 | 2021 | 302 | 0.720 |
Why?
|
Anger | 1 | 2022 | 401 | 0.720 |
Why?
|
Hormone Replacement Therapy | 2 | 2024 | 740 | 0.710 |
Why?
|
Aspirin | 3 | 2021 | 3268 | 0.710 |
Why?
|
Cholangiocarcinoma | 2 | 2022 | 506 | 0.700 |
Why?
|
Interleukins | 4 | 2023 | 788 | 0.690 |
Why?
|
Platelet-Rich Plasma | 1 | 2021 | 173 | 0.670 |
Why?
|
Comorbidity | 6 | 2019 | 10362 | 0.660 |
Why?
|
Musculoskeletal System | 1 | 2021 | 175 | 0.650 |
Why?
|
Bacterial Load | 1 | 2018 | 153 | 0.630 |
Why?
|
Surgical Wound Infection | 3 | 2021 | 1530 | 0.620 |
Why?
|
Interleukin-8 | 1 | 2021 | 685 | 0.620 |
Why?
|
Enterococcus faecium | 1 | 2018 | 102 | 0.620 |
Why?
|
Catheter-Related Infections | 2 | 2017 | 253 | 0.610 |
Why?
|
Enterococcus faecalis | 1 | 2018 | 251 | 0.590 |
Why?
|
Running | 1 | 2021 | 476 | 0.570 |
Why?
|
Homes for the Aged | 1 | 2019 | 260 | 0.570 |
Why?
|
Hepacivirus | 3 | 2019 | 1371 | 0.540 |
Why?
|
Catheterization, Central Venous | 2 | 2017 | 513 | 0.540 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2018 | 253 | 0.530 |
Why?
|
Reproduction | 1 | 2020 | 666 | 0.520 |
Why?
|
Physical Examination | 1 | 2021 | 1231 | 0.500 |
Why?
|
Anthropometry | 1 | 2019 | 1344 | 0.490 |
Why?
|
Hepatitis C, Chronic | 2 | 2019 | 1026 | 0.480 |
Why?
|
Organ Transplantation | 1 | 2024 | 1131 | 0.470 |
Why?
|
Baseball | 1 | 2014 | 88 | 0.450 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2021 | 2277 | 0.450 |
Why?
|
Cholera Vaccines | 1 | 2015 | 263 | 0.430 |
Why?
|
Equipment Contamination | 3 | 2018 | 182 | 0.430 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2019 | 694 | 0.410 |
Why?
|
Health Personnel | 4 | 2019 | 3203 | 0.400 |
Why?
|
Nursing Homes | 1 | 2019 | 1029 | 0.400 |
Why?
|
Maryland | 4 | 2019 | 276 | 0.390 |
Why?
|
Interleukin-6 | 1 | 2021 | 3194 | 0.390 |
Why?
|
Sex Factors | 7 | 2022 | 10398 | 0.380 |
Why?
|
Staphylococcal Infections | 1 | 2019 | 1403 | 0.350 |
Why?
|
Early Detection of Cancer | 1 | 2023 | 3051 | 0.350 |
Why?
|
Upper Extremity | 1 | 2014 | 642 | 0.340 |
Why?
|
Liver Cirrhosis | 1 | 2019 | 1838 | 0.340 |
Why?
|
Alleles | 2 | 2019 | 6942 | 0.330 |
Why?
|
Risk Factors | 16 | 2024 | 71974 | 0.330 |
Why?
|
Cholera | 1 | 2015 | 780 | 0.330 |
Why?
|
Decision Support Techniques | 1 | 2019 | 1957 | 0.330 |
Why?
|
Humans | 51 | 2024 | 739398 | 0.310 |
Why?
|
Gender Identity | 2 | 2023 | 674 | 0.300 |
Why?
|
Mood Disorders | 1 | 2013 | 1102 | 0.290 |
Why?
|
Acinetobacter baumannii | 2 | 2018 | 106 | 0.280 |
Why?
|
Minority Groups | 2 | 2023 | 1197 | 0.270 |
Why?
|
Female | 28 | 2024 | 378853 | 0.260 |
Why?
|
Bile Duct Neoplasms | 2 | 2021 | 564 | 0.260 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4920 | 0.250 |
Why?
|
Menopause | 2 | 2024 | 1613 | 0.250 |
Why?
|
Venous Thrombosis | 1 | 2014 | 1232 | 0.250 |
Why?
|
Adenocarcinoma | 1 | 2022 | 6318 | 0.250 |
Why?
|
Genetic Variation | 2 | 2019 | 6539 | 0.250 |
Why?
|
Registries | 1 | 2020 | 8039 | 0.240 |
Why?
|
Incidence | 5 | 2024 | 20913 | 0.240 |
Why?
|
Male | 25 | 2024 | 349022 | 0.230 |
Why?
|
Chile | 2 | 2021 | 236 | 0.230 |
Why?
|
Sexual Behavior | 2 | 2023 | 2040 | 0.230 |
Why?
|
Patient Education as Topic | 1 | 2013 | 2275 | 0.230 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2016 | 2196 | 0.230 |
Why?
|
Ultrasonography | 3 | 2021 | 5941 | 0.220 |
Why?
|
Primary Health Care | 2 | 2023 | 4537 | 0.220 |
Why?
|
Hip Joint | 2 | 2020 | 1000 | 0.220 |
Why?
|
Aged | 18 | 2022 | 162698 | 0.220 |
Why?
|
Suppositories | 1 | 2022 | 15 | 0.210 |
Why?
|
Baltimore | 3 | 2018 | 230 | 0.210 |
Why?
|
Middle Aged | 20 | 2022 | 212863 | 0.210 |
Why?
|
HIV Infections | 3 | 2023 | 16764 | 0.210 |
Why?
|
Prospective Studies | 8 | 2022 | 53037 | 0.200 |
Why?
|
England | 1 | 2023 | 522 | 0.200 |
Why?
|
Risk Assessment | 2 | 2020 | 23294 | 0.200 |
Why?
|
Intensive Care Units | 4 | 2018 | 3672 | 0.200 |
Why?
|
Indians, South American | 1 | 2021 | 36 | 0.200 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4220 | 0.200 |
Why?
|
Administration, Oral | 2 | 2022 | 3909 | 0.190 |
Why?
|
Adult | 16 | 2024 | 213394 | 0.190 |
Why?
|
Acinetobacter Infections | 2 | 2018 | 68 | 0.180 |
Why?
|
Administration, Topical | 1 | 2022 | 687 | 0.180 |
Why?
|
Infection Control | 2 | 2018 | 968 | 0.180 |
Why?
|
Sarcoma, Kaposi | 1 | 2023 | 365 | 0.180 |
Why?
|
Progestins | 1 | 2022 | 303 | 0.180 |
Why?
|
Opportunistic Infections | 1 | 2023 | 389 | 0.180 |
Why?
|
Athletic Injuries | 2 | 2021 | 1151 | 0.180 |
Why?
|
Herpes Simplex | 1 | 2023 | 466 | 0.170 |
Why?
|
Gallbladder | 1 | 2021 | 300 | 0.170 |
Why?
|
Psychotic Disorders | 1 | 2013 | 3028 | 0.170 |
Why?
|
Infectious Disease Transmission, Professional-to-Patient | 1 | 2018 | 35 | 0.160 |
Why?
|
Michigan | 1 | 2019 | 349 | 0.160 |
Why?
|
Femur Neck | 1 | 2019 | 309 | 0.160 |
Why?
|
Vancomycin Resistance | 1 | 2018 | 130 | 0.150 |
Why?
|
Hip | 1 | 2019 | 257 | 0.150 |
Why?
|
Gonadal Steroid Hormones | 1 | 2022 | 711 | 0.150 |
Why?
|
Hospitals | 4 | 2021 | 3916 | 0.150 |
Why?
|
Progesterone | 1 | 2022 | 772 | 0.150 |
Why?
|
Case-Control Studies | 3 | 2022 | 21694 | 0.150 |
Why?
|
Cumulative Trauma Disorders | 1 | 2018 | 146 | 0.150 |
Why?
|
Perineum | 1 | 2018 | 211 | 0.150 |
Why?
|
Estrogen Replacement Therapy | 1 | 2024 | 1203 | 0.150 |
Why?
|
Morbidity | 1 | 2022 | 1763 | 0.150 |
Why?
|
Proportional Hazards Models | 3 | 2022 | 12328 | 0.150 |
Why?
|
Nutrition Surveys | 1 | 2024 | 1645 | 0.150 |
Why?
|
Infection Control Practitioners | 1 | 2016 | 12 | 0.150 |
Why?
|
Drug Combinations | 1 | 2022 | 1959 | 0.140 |
Why?
|
Cytomegalovirus Infections | 1 | 2023 | 808 | 0.140 |
Why?
|
Egypt | 1 | 2016 | 100 | 0.140 |
Why?
|
Physical Therapy Modalities | 1 | 2020 | 545 | 0.140 |
Why?
|
Odds Ratio | 2 | 2021 | 9846 | 0.140 |
Why?
|
Age Factors | 4 | 2022 | 18349 | 0.140 |
Why?
|
Arthralgia | 1 | 2020 | 457 | 0.140 |
Why?
|
Neoplasm Staging | 2 | 2021 | 10961 | 0.140 |
Why?
|
Firearms | 1 | 2023 | 599 | 0.130 |
Why?
|
Aged, 80 and over | 6 | 2022 | 57650 | 0.130 |
Why?
|
Digestive System Surgical Procedures | 1 | 2021 | 568 | 0.130 |
Why?
|
Health Services Needs and Demand | 1 | 2023 | 1409 | 0.130 |
Why?
|
United States | 7 | 2021 | 69573 | 0.130 |
Why?
|
Estrogens | 1 | 2022 | 1561 | 0.120 |
Why?
|
International Classification of Diseases | 2 | 2018 | 867 | 0.120 |
Why?
|
United States Department of Veterans Affairs | 1 | 2019 | 873 | 0.120 |
Why?
|
Immunization Schedule | 1 | 2015 | 219 | 0.120 |
Why?
|
Vaccines, Attenuated | 1 | 2015 | 344 | 0.120 |
Why?
|
Logistic Models | 3 | 2018 | 13402 | 0.120 |
Why?
|
Athletes | 1 | 2021 | 1086 | 0.120 |
Why?
|
Rectum | 1 | 2018 | 900 | 0.120 |
Why?
|
Sex Characteristics | 1 | 2024 | 2583 | 0.110 |
Why?
|
Spouses | 1 | 2016 | 283 | 0.110 |
Why?
|
HIV-1 | 2 | 2023 | 6931 | 0.110 |
Why?
|
Probability | 1 | 2019 | 2500 | 0.110 |
Why?
|
Fracture Fixation, Internal | 1 | 2019 | 911 | 0.110 |
Why?
|
Infant, Newborn | 2 | 2023 | 25470 | 0.110 |
Why?
|
Suicide | 1 | 2023 | 1469 | 0.110 |
Why?
|
Femur | 1 | 2019 | 1297 | 0.110 |
Why?
|
Feces | 1 | 2018 | 1389 | 0.110 |
Why?
|
Esophageal Neoplasms | 1 | 2022 | 1575 | 0.110 |
Why?
|
Carrier State | 1 | 2016 | 518 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2020 | 3193 | 0.100 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2020 | 3453 | 0.100 |
Why?
|
Joint Instability | 1 | 2019 | 790 | 0.100 |
Why?
|
Health Status Disparities | 1 | 2023 | 1776 | 0.100 |
Why?
|
Environmental Monitoring | 1 | 2018 | 1408 | 0.100 |
Why?
|
Pseudomonas Infections | 1 | 2016 | 607 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2021 | 2694 | 0.100 |
Why?
|
Cohort Studies | 7 | 2023 | 40389 | 0.100 |
Why?
|
Hip Fractures | 1 | 2019 | 953 | 0.100 |
Why?
|
Clostridium Infections | 1 | 2018 | 549 | 0.100 |
Why?
|
Bile Ducts, Extrahepatic | 2 | 2021 | 49 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1413 | 0.090 |
Why?
|
Lower Extremity | 1 | 2018 | 1145 | 0.090 |
Why?
|
Antiretroviral Therapy, Highly Active | 1 | 2019 | 1896 | 0.090 |
Why?
|
Viral Load | 1 | 2019 | 3299 | 0.090 |
Why?
|
Antibodies, Bacterial | 1 | 2015 | 1465 | 0.090 |
Why?
|
Travel | 1 | 2015 | 787 | 0.090 |
Why?
|
Bile Ducts, Intrahepatic | 2 | 2021 | 294 | 0.090 |
Why?
|
Retrospective Studies | 7 | 2021 | 76631 | 0.080 |
Why?
|
Vibrio cholerae | 1 | 2015 | 806 | 0.080 |
Why?
|
Young Adult | 5 | 2020 | 56255 | 0.080 |
Why?
|
Socioeconomic Factors | 2 | 2021 | 7726 | 0.080 |
Why?
|
Pseudomonas aeruginosa | 1 | 2016 | 1208 | 0.080 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13880 | 0.080 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 24714 | 0.080 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1123 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2019 | 3945 | 0.070 |
Why?
|
Survival Analysis | 1 | 2019 | 10247 | 0.070 |
Why?
|
Prevalence | 1 | 2023 | 15153 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 3233 | 0.070 |
Why?
|
Electronic Health Records | 2 | 2019 | 4426 | 0.070 |
Why?
|
Survival Rate | 1 | 2020 | 12761 | 0.070 |
Why?
|
Academic Medical Centers | 1 | 2016 | 2749 | 0.070 |
Why?
|
Adolescent | 4 | 2021 | 85405 | 0.070 |
Why?
|
Obesity | 2 | 2023 | 12643 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5272 | 0.060 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4320 | 0.060 |
Why?
|
Medicare | 1 | 2021 | 6497 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 8960 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3143 | 0.050 |
Why?
|
Body Mass Index | 2 | 2018 | 12655 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3248 | 0.050 |
Why?
|
Health Behavior | 1 | 2013 | 2624 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10534 | 0.050 |
Why?
|
Homicide | 1 | 2023 | 287 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2021 | 209 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2019 | 12178 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 7897 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17384 | 0.040 |
Why?
|
Tooth Loss | 1 | 2021 | 195 | 0.040 |
Why?
|
Anticoagulants | 1 | 2014 | 4582 | 0.040 |
Why?
|
Follow-Up Studies | 1 | 2020 | 38942 | 0.040 |
Why?
|
Time Factors | 1 | 2020 | 40050 | 0.040 |
Why?
|
Zambia | 1 | 2019 | 260 | 0.040 |
Why?
|
Hepatitis | 1 | 2019 | 220 | 0.040 |
Why?
|
Patients' Rooms | 1 | 2018 | 63 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2019 | 497 | 0.040 |
Why?
|
Postoperative Complications | 1 | 2019 | 15194 | 0.040 |
Why?
|
Knee | 1 | 2018 | 275 | 0.040 |
Why?
|
Interferons | 1 | 2020 | 703 | 0.040 |
Why?
|
Genotype | 2 | 2023 | 12951 | 0.040 |
Why?
|
Treatment Outcome | 2 | 2019 | 62693 | 0.030 |
Why?
|
Child | 2 | 2021 | 77033 | 0.030 |
Why?
|
Hospitals, University | 1 | 2018 | 567 | 0.030 |
Why?
|
Muscle Strength | 1 | 2018 | 582 | 0.030 |
Why?
|
Organ Size | 1 | 2019 | 2247 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2019 | 2974 | 0.030 |
Why?
|
Drug Resistance, Viral | 1 | 2019 | 829 | 0.030 |
Why?
|
Specialization | 1 | 2018 | 776 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2018 | 12237 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 35326 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 563 | 0.030 |
Why?
|
World Health Organization | 1 | 2018 | 1321 | 0.030 |
Why?
|
Gene Frequency | 1 | 2019 | 3585 | 0.030 |
Why?
|
Colon | 1 | 2021 | 1771 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2602 | 0.030 |
Why?
|
Virus Replication | 1 | 2020 | 2529 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2023 | 15500 | 0.030 |
Why?
|
Range of Motion, Articular | 1 | 2018 | 1576 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1890 | 0.030 |
Why?
|
Pandemics | 2 | 2023 | 8274 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2019 | 1936 | 0.020 |
Why?
|
Bacteremia | 1 | 2017 | 957 | 0.020 |
Why?
|
Carcinoma | 1 | 2021 | 2361 | 0.020 |
Why?
|
Anti-Bacterial Agents | 2 | 2018 | 7136 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 2950 | 0.020 |
Why?
|
Guideline Adherence | 1 | 2018 | 2261 | 0.020 |
Why?
|
Blood Pressure | 1 | 2021 | 8554 | 0.020 |
Why?
|
Research Design | 1 | 2021 | 5959 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 3908 | 0.010 |
Why?
|
Databases, Factual | 1 | 2018 | 7690 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5702 | 0.010 |
Why?
|
Phenotype | 1 | 2019 | 16301 | 0.010 |
Why?
|
Lung | 1 | 2020 | 9782 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 28901 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7274 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2021 | 15070 | 0.010 |
Why?
|